Conference item icon

Conference item

Valuing the effect sizes hypothesized in phase 3 trials of targeted therapies in oncology

Abstract:
This abstract was not included in this publication as it was already published. See Annals of Oncology, Volume 27, Issue suppl_6, 1 October 2016, 317P (10.1093/annonc/mdw366.02) - Oxford University Press.
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Publisher's version

Actions


Access Document


Files:
Publisher copy:
10.1186/s13063-017-1902-y

Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
NDORMS; CSM
Attwood, S More by this author
Scudder, C More by this author
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
NDORMS; CSM
ORCID:
0000-0002-6695-5390
Publisher:
BioMed Central Publisher's website
Volume:
18
Issue:
S1:200
Pages:
199
Series:
ICTMC 2017: 4th International Clinical Trials Methodology Conference and the 38th Annual Meeting of the Society for Clinical Trials
Publication date:
2017-05-08
Acceptance date:
2016-12-22
DOI:
Pubs id:
pubs:732802
URN:
uri:80a87da8-419a-48d9-8fc1-5918c42d5390
UUID:
uuid:80a87da8-419a-48d9-8fc1-5918c42d5390
Local pid:
pubs:732802

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP